Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Stock
Stocks
600329
CNE000001808
Pharmaceuticals
|
End-of-day quote
Shanghai S.E.
2026-10-27
|
5-day change | 1st Jan Change | ||
| 40.86 CNY | -2.13% |
|
+0.10% | -10.43% |
| 10-12 | Tianjin Pharmaceutical Da Ren Tang Wins China Approval for Pain Relief Patches | MT |
| 10-09 | Tianjin Pharma's Plant Secures Nod for Pain-Relief Patches Production | MT |
| Market Cap | 26.75B 4.01B 3.6B 3.32B 3.01B 5.63B 381B 5.7B 39.85B 15.83B 200B 15.06B 14.73B 633B | P/E 2026 * |
30.5x | P/E 2027 * | 26.5x |
|---|---|---|---|---|---|
| Enterprise Value | 26.75B 4.01B 3.6B 3.32B 3.01B 5.63B 381B 5.7B 39.85B 15.83B 200B 15.06B 14.73B 633B | EV / Sales 2026 * |
5.42x | EV / Sales 2027 * | 5x |
| Free-Float |
31.71% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | -2.13% | ||
| 1 week | +0.10% | ||
| Current month | +15.69% | ||
| 1 month | +16.31% | ||
| 3 months | +10.49% | ||
| 6 months | +4.74% | ||
| Current year | -10.43% |
| 1 week | 40.45 |  | 42.05 |
| 1 month | 34.54 | | 42.7 |
| Current year | 33.83 | | 48.2 |
| 1 year | 33.83 | | 50.95 |
| 3 years | 23.4 | | 50.97 |
| 5 years | 17.98 | | 56.26 |
| 10 years | 11.8 | | 56.26 |
| Manager | Title | Age | Since |
|---|---|---|---|
Hong Chen
CEO | Chief Executive Officer | 56 | 2026-09-03 |
Jian Ma
DFI | Director of Finance/CFO | 42 | - |
Hong Zhou
PRN | Corporate Officer/Principal | 56 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Hong Zhou
BRD | Director/Board Member | 56 | 2019-05-14 |
Min Guo
CHM | Chairman | 55 | 2021-09-05 |
Jian Hua Xing
BRD | Director/Board Member | 55 | 2021-12-09 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.13% | +0.10% | -4.69% | +28.09% | 4.08B | |
| +0.22% | -0.14% | +55.12% | +128.82% | 1,140B | |
| +0.91% | +3.61% | +41.21% | +84.57% | 641B | |
| -0.12% | -0.93% | +25.59% | +106.14% | 507B | |
| +0.63% | +2.33% | +49.21% | +67.82% | 383B | |
| +0.86% | -4.37% | +61.16% | +37.93% | 347B | |
| +1.02% | +1.80% | +24.84% | +53.75% | 293B | |
| -0.25% | +1.62% | +2.20% | +26.65% | 266B | |
| +0.75% | +2.05% | +53.85% | +71.25% | 240B | |
| +0.25% | +1.64% | +32.05% | +107.62% | 197B | |
| Average | +0.21% | +2.54% | +34.05% | +71.26% | 401.79B | |
| Weighted average by Cap. | +0.44% | +2.98% | +42.16% | +88.42% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 4.93B 739M 664M 613M 556M 1.04B 70.23B 1.05B 7.35B 2.92B 36.81B 2.78B 2.72B 117B | 5.35B 802M 720M 665M 603M 1.13B 76.22B 1.14B 7.97B 3.17B 39.95B 3.01B 2.95B 127B |
| Net income | 1.04B 155M 139M 129M 117M 218M 14.76B 221M 1.54B 613M 7.73B 583M 571M 24.53B | 1.18B 178M 159M 147M 133M 249M 16.86B 252M 1.76B 701M 8.84B 666M 652M 28.03B |
| Net Debt | - | - |
Employees
3,890
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-27 | CN¥40.86 | -2.13% | 3,842,700 |
| 26-10-26 | CN¥41.75 | +1.63% | 6,530,222 |
| 26-10-23 | CN¥41.08 | -0.29% | 7,156,567 |
| 26-10-22 | CN¥41.20 | -0.05% | 7,252,369 |
| 26-10-21 | CN¥41.22 | +0.98% | 8,116,389 |
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
40.86
Average target price
-
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 600329 Stock
Select your edition
All financial news and data tailored to specific country editions
